Avenue Therapeutics, Inc. (ATXI) earnings
ATXI earnings moved a median of -1.35% by the close. Quarterly and annual ATXI reports and results, each read against the price at its own news timestamp. Back to the ATXI overview →
15 measured ATXI earnings events.
Where these ATXI earnings landedvs 14 measured ATXI earnings reactions
| Middle 50% of ATXI earnings reactions | -3.22% to +1.63% |
|---|---|
| Median reaction (to close) | -1.35% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 ATXI earnings events with a measured close landed between -3.22% and +1.63%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -47.69% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.67% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +20.57% | +61.47% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +1.20% | -3.33% | |
| Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -3.23% | +3.76% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -3.23% | +3.76% | |
| Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | — | +1.63% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | — | +1.63% | |
| Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -0.27% | -1.62% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +3.54% | -1.09% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -3.85% | -3.61% | |
| Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | +0.07% | -2.88% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.07% | -2.88% |
Keep exploring
More ATXI: analyst actions → · SEC filings → · ATXI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Protagenic Therapeutics, Inc. (PTIX) | 121 | 0.00% | 39% |
| Xenetic Biosciences, Inc. (XBIO) | 121 | 0.00% | 38% |
| CARL ZEISS MEDI UNSP/ADR (CZMWY) | 120 | -0.21% | 21% |
| HEMP NATURALS INC (HPMM) | 120 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.